Skip to content
10-Q

Quarterly Report

FINCH THERAPEUTICS GROUP, INC.

0000950170-23-060651

← back to feed
Filed
Nov 8, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 2, 2023 1.61M sh
Shares Diluted Q3 2023 · Sep 30, 2023 1.6M sh
Shares Diluted Q3 2023 · Sep 30, 2023 1.6M sh
Shares Diluted restated Q3 2023 · Sep 30, 2022 1.59M sh
Shares Diluted restated Q3 2023 · Sep 30, 2022 1.59M sh
Capex Q3 2023 · Sep 30, 2023 $14K
Capex Q3 2023 · Sep 30, 2022 $2.13M
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$27.8M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$60.58M
Long Term Debt Q3 2023 · Sep 30, 2023 $0
Long Term Debt Q3 2023 · Dec 31, 2022 $14.65M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $28.78M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $71.04M
Cash And Equivalents Q3 2023 · Sep 30, 2022 $85.29M
Stockholders Equity Q3 2023 · Sep 30, 2023 $25.81M
Stockholders Equity Q3 2023 · Jun 30, 2023 $27.89M
Stockholders Equity Q3 2023 · Mar 31, 2023 $34.54M
Stockholders Equity Q3 2023 · Dec 31, 2022 $95.71M
Stockholders Equity Q3 2023 · Sep 30, 2022 $120.87M
Stockholders Equity Q3 2023 · Jun 30, 2022 $159.09M
Stockholders Equity Q3 2023 · Mar 31, 2022 $179.79M
Stockholders Equity Q3 2023 · Dec 31, 2021 $202.22M
Current Liabilities Q3 2023 · Sep 30, 2023 $4.88M
Current Liabilities Q3 2023 · Dec 31, 2022 $14.69M
Total Liabilities Q3 2023 · Sep 30, 2023 $33.68M
Total Liabilities Q3 2023 · Dec 31, 2022 $67.23M
Current Assets Q3 2023 · Sep 30, 2023 $29.92M
Current Assets Q3 2023 · Dec 31, 2022 $74.55M
Total Assets Q3 2023 · Sep 30, 2023 $59.49M
Total Assets Q3 2023 · Dec 31, 2022 $162.94M
Eps Diluted Q3 2023 · Sep 30, 2023 −$1.51
Eps Diluted Q3 2023 · Sep 30, 2023 −$44.70
Eps Diluted restated Q3 2023 · Sep 30, 2022 −$25.38
Eps Diluted restated Q3 2023 · Sep 30, 2022 −$55.22
Eps Basic Q3 2023 · Sep 30, 2023 −$1.51
Eps Basic Q3 2023 · Sep 30, 2023 −$44.70
Eps Basic restated Q3 2023 · Sep 30, 2022 −$25.38
Eps Basic restated Q3 2023 · Sep 30, 2022 −$55.22
Sga Expense Q3 2023 · Sep 30, 2023 $3.74M
Sga Expense Q3 2023 · Sep 30, 2023 $22.23M
Sga Expense Q3 2023 · Sep 30, 2022 $9.58M
Sga Expense Q3 2023 · Sep 30, 2022 $27.15M
Rd Expense Q3 2023 · Sep 30, 2023 $0
Rd Expense Q3 2023 · Sep 30, 2023 $7.2M
Rd Expense Q3 2023 · Sep 30, 2022 $11.86M
Rd Expense Q3 2023 · Sep 30, 2022 $41.31M
Net Income Q3 2023 · Sep 30, 2023 −$2.42M
Net Income Q3 2023 · Sep 30, 2023 −$71.71M
Net Income Q3 2023 · Jun 30, 2023 −$6.95M
Net Income Q3 2023 · Mar 31, 2023 −$62.35M
Net Income Q3 2023 · Sep 30, 2022 −$40.37M
Net Income Q3 2023 · Sep 30, 2022 −$87.64M
Net Income Q3 2023 · Jun 30, 2022 −$22.7M
Net Income Q3 2023 · Mar 31, 2022 −$24.57M
Operating Income Q3 2023 · Sep 30, 2023 −$3.78M
Operating Income Q3 2023 · Sep 30, 2023 −$79.45M
Operating Income Q3 2023 · Sep 30, 2022 −$40.63M
Operating Income Q3 2023 · Sep 30, 2022 −$87.84M
Revenue Q3 2023 · Sep 30, 2023 $0
Revenue Q3 2023 · Sep 30, 2023 $107K
Revenue Q3 2023 · Sep 30, 2022 $138K
Revenue Q3 2023 · Sep 30, 2022 $853K